SEC 13F Intelligence

Atwood & Palmer Inc / VRTX

Atwood & Palmer Inc’s Vertex Pharmaceuticals Inc Position

Does Atwood & Palmer Inc own Vertex Pharmaceuticals Inc (VRTX)? Yes56.4K shares worth $28M (+1.49% of its 13F portfolio) as of Q2 2026, up from 55.8K shares the prior filed quarter.

Position Value
$28M
Q2 2026
Shares
56.4K
% of Portfolio
+1.49%
Quarters Held
13
currently held

Position History VRTX

Reported value by quarter
Q2 ’23: $18MQ2 ’23Q3 ’23: $18MQ4 ’23: $21MQ4 ’23Q1 ’24: $23MQ2 ’24: $25MQ2 ’24Q3 ’24: $25MQ4 ’24: $22MQ4 ’24Q1 ’25: $27MQ2 ’25: $25MQ2 ’25Q3 ’25: $22MQ4 ’25: $25MQ4 ’25Q1 ’26: $25MQ2 ’26: $28MQ2 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202656.4K$28M+1.49%
Q1 202655.8K$25M+1.40%
Q4 202555.4K$25M+1.43%
Q3 202555.3K$22M+1.27%
Q2 202555.2K$25M+1.54%
Q1 202555.0K$27M+1.85%
Q4 202455.4K$22M+1.53%
Q3 202454.3K$25M+1.72%
Q2 202454.3K$25M+1.93%
Q1 202454.1K$23M+1.72%
Q4 202352.5K$21M+1.73%
Q3 202352.3K$18M+1.59%
Q2 202352.2K$18M+1.64%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Atwood & Palmer Inc’s full portfolio or all institutional holders of VRTX.